These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 3813579

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. [Phase II study on MCNU in patients with advanced or recurrent gastrointestinal cancer].
    Niimoto M, Yoshinaka K, Hattori T, Kobayashi S, Hosoma S, Ogawa Y, Iwamori S, Nagata N, Yamagata S, Nishimawari K.
    Gan To Kagaku Ryoho; 1985 Sep; 12(9):1813-9. PubMed ID: 4037810
    [Abstract] [Full Text] [Related]

  • 5. Biologic activity of MCNU: a new antitumor agent.
    Sekido S, Ninomiya K, Iwasaki M.
    Cancer Treat Rep; 1979 Jun; 63(6):961-70. PubMed ID: 466655
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Beneficial treatment with methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in a patient with primary myelofibrosis.
    Asano Y, Shimokawa M, Okabe H, Sanefuji H, Kato K.
    Acta Haematol; 1991 Jun; 85(2):103-4. PubMed ID: 2024552
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Randomized controlled study of methyl 6-[3-(2-chloroethyl)-3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside (MCNU) in comparison with busulfan for chronic myelogenous leukemia].
    Masaoka T, Kimura K, Miyazaki T, Hirota Y, Nakamura T, Yasunaga K, Ohkubo H, Okamoto Y, Fujitake H, Kitani T.
    Gan To Kagaku Ryoho; 1985 May; 12(5):1111-8. PubMed ID: 3888116
    [Abstract] [Full Text] [Related]

  • 10. Antitumor activity and toxicity of methyl 6-[3-(2-chloroethyl)- 3-nitrosoureido]-6-deoxy-alpha-D-glucopyranoside in experimental animals.
    Fujimoto S, Tashiro T, Ogawa M.
    Gan; 1984 Oct; 75(10):937-46. PubMed ID: 6510639
    [Abstract] [Full Text] [Related]

  • 11. [Effect of MCNU on brain tumors. Part II: Clinical experience with MCNU on malignant brain tumors].
    Wakabayashi T, Yoshida J, Kito A, Inoue I, Kobayashi T, Kageyama N.
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2729-37. PubMed ID: 6095764
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Recombinant mutant human tumor necrosis factor-alpha (TNF-SAM2) immunotherapy with ranimustine chemotherapy and concurrent radiation therapy for malignant astrocytomas.
    Fukushima T, Yamamoto M, Oshiro S, Tsugu H, Hirakawa K, Soma G.
    Anticancer Res; 2003 Dec; 23(6a):4473-81. PubMed ID: 14666736
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
    Watanabe M, Takeda N, Tanaka R.
    Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
    [Abstract] [Full Text] [Related]

  • 19. Neurotoxicity of local administration of two nitrosoureas in malignant gliomas.
    Yamashima T, Yamashita J, Shoin K.
    Neurosurgery; 1990 May; 26(5):794-9. PubMed ID: 2352597
    [Abstract] [Full Text] [Related]

  • 20. [Clinical pharmacokinetics of carboplatin and MCNU in malignant brain tumor and normal brain tissues].
    Shinohara C, Matsumoto K, Kuriyama M, Adachi H, Ono Y, Higashi H, Furuta T, Ohmoto T.
    Gan To Kagaku Ryoho; 1994 Jul; 21(8):1163-8. PubMed ID: 8031157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.